Media

December 10, 2024: France’s MaaT Pharma presented early access data at ASH for its microbiome based treatment for GvHD – a formal study will read out early next year – Biotech TV

Date : December 11, 2024

To see the interview, click here

December 10, 2024: MaaT Pharma Presented Positive Updated Data on MaaT013 in the Early Access Program at ASH 2024 Annual Meeting

Replay: KOL insights and MaaT013 Data from ASH 2024 Meeting